Literature DB >> 9403695

Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.

E F Petricoin1, S Ito, B L Williams, S Audet, L F Stancato, A Gamero, K Clouse, P Grimley, A Weiss, J Beeler, D S Finbloom, E W Shores, R Abraham, A C Larner.   

Abstract

Signal transduction through both cytokine and lymphocyte antigen receptors shares some common pathways by which they initiate cellular responses, such as activation of mitogen-activated protein kinase(s). However, other signalling components appear to be uniquely coupled to each receptor. For example, the interferon receptors transduce regulatory signals through the JAK/STAT pathway, resulting in an inhibition of growth and of antiviral effects, whereas this pathway apparently plays no role in T-cell-receptor (TCR)-dependent gene expression. Conversely, signal transduction through the TCR requires the tyrosine kinases Lck and ZAP-70 and the tyrosine phosphatase CD45. Here we show that, unexpectedly, transmission of growth-inhibitory signals by interferon-alpha (IFN-alpha) in T cells requires the expression and association of CD45, Lck and ZAP-70 with the IFN-alpha-receptor signalling complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403695     DOI: 10.1038/37648

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  36 in total

1.  Tat as one key to HIV-induced immune pathogenesis and Tat (correction of Pat) toxoid as an important component of a vaccine.

Authors:  R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 2.  T-cell proliferation in vivo and the role of cytokines.

Authors:  J Sprent; X Zhang; S Sun; D Tough
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

3.  Control of type I interferon-induced cell death by Orai1-mediated calcium entry in T cells.

Authors:  Chanyu Yue; Jonathan Soboloff; Ana M Gamero
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

4.  Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms.

Authors:  Ana M Gamero; Ramesh Potla; Shuji Sakamoto; Darren P Baker; Robert Abraham; Andrew C Larner
Journal:  Cell Signal       Date:  2005-12-06       Impact factor: 4.315

5.  Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus.

Authors:  Bo Chi; Harold L Dickensheets; Kirsten M Spann; Marc A Alston; Cindy Luongo; Laure Dumoutier; Jiaying Huang; Jean-Christophe Renauld; Sergei V Kotenko; Mario Roederer; Judy A Beeler; Raymond P Donnelly; Peter L Collins; Ronald L Rabin
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

Review 6.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

7.  Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

Authors:  C Boni; A Bertoletti; A Penna; A Cavalli; M Pilli; S Urbani; P Scognamiglio; R Boehme; R Panebianco; F Fiaccadori; C Ferrari
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

8.  T-cell receptor early signalling complex activation in response to interferon-alpha receptor stimulation.

Authors:  Claire N Stevens; Ann-Marie Simeone; Susan John; Zamal Ahmed; Orso M Lucherini; C Tatiana Baldari; John E Ladbury
Journal:  Biochem J       Date:  2010-05-27       Impact factor: 3.857

9.  Lymphadenopathy in a novel mouse model of Bartonella-induced cat scratch disease results from lymphocyte immigration and proliferation and is regulated by interferon-alpha/beta.

Authors:  Stefanie Kunz; Karin Oberle; Anna Sander; Christian Bogdan; Ulrike Schleicher
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

10.  CD45RC isoform expression identifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients.

Authors:  Laurence Ordonez; Isabelle Bernard; Fatima-Ezzahra L'faqihi-Olive; Jan Willem Cohen Tervaert; Jan Damoiseaux; Abdelhadi Saoudi
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.